BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 1336921)

  • 1. Women's evaluation of three early abortion methods.
    Holmgren K
    Acta Obstet Gynecol Scand; 1992 Dec; 71(8):616-23. PubMed ID: 1336921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C; Olund A
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
    Grimes DA; Mishell DR; David HP
    Contraception; 1992 Jul; 46(1):1-10. PubMed ID: 1424618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
    Slade P; Heke S; Fletcher J; Stewart P
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
    Henshaw R; Naji S; Russell I; Templeton A
    Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
    Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
    Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
    Gupta JK; Johnson N
    Contraception; 1992 Nov; 46(5):489-97. PubMed ID: 1458895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditions for choosing between drug-induced and surgical abortions.
    Bachelot A; Cludy L; Spira A
    Contraception; 1992 Jun; 45(6):547-59. PubMed ID: 1617964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
    Ulmann A; Silvestre L; Chemama L; Rezvani Y; Renault M; Aguillaume CJ; Baulieu EE
    Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
    Tang GW; Lau OW; Yip P
    Contraception; 1993 Sep; 48(3):267-76. PubMed ID: 8222656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
    Norman JE; Thong KJ; Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprogestin drugs: research and clinical use in Sweden.
    Bygdeman M; Swahn ML
    Law Med Health Care; 1992; 20(3):157-60. PubMed ID: 1434756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
    Urquhart DR; Templeton AA
    Br J Obstet Gynaecol; 1991 Apr; 98(4):396-9. PubMed ID: 2031899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood loss in termination of early pregnancy with mifepristone and gemeprost.
    Prasad RN; Choolani M; Roy A; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):329-31. PubMed ID: 8546658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.